Liu Lijuan, Zhen Donghu, Fu Songbo, Sun Weiming, Li Hongli, Zhao Nan, Hou Lijie, Tang Xulei
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Diabetol Metab Syndr. 2022 Apr 18;14(1):54. doi: 10.1186/s13098-022-00827-8.
Diabetes mellitus increases the risk of developing hypertension. The relationship between glycosylated hemoglobin A1c (HbA1c) level and incident hypertension remains controversial. This study examined the associations of the baseline level and change in the HbA1c level over 3 years with incident hypertension in non-diabetic individuals.
This community-based cohort study was conducted with 2591 individuals aged 40-75 years without hypertension or diabetes at baseline, who participated in a longitudinal (REACTION) study program. Questionnaires were administered during interviews, and anthropometric and laboratory measurements were performed at baseline (2011) and follow-up (2014-2015). Multivariate logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of incident hypertension.
Over a median follow-up period of 3.08 years (interquartile range 3.00, 3.25), 384 (14.82%) subjects developed hypertension. In the fully adjusted linear regression models, change in HbA1c remained significantly associated with changes in systolic blood pressure and diastolic blood pressure [β-coefficient (95% CI), 4.421 (2.811-6.032), 1.681 (0.695-2.667)]. Logistic regression analyses showed that baseline HbA1c level was positively associated with incident hypertension in the unadjusted model; however, the association was no longer significant after further adjustment. Change in HbA1c was positively associated with the development of hypertension, both as a categorical variable stratified by tertiles [adjusted OR (95% CI) in the highest tertile was 1.690 (1.240-2.303) versus the lowest tertile)] and as a continuous variable [adjusted OR (95% CI), 1.242 (1.106-1.394)], independent of age, sex, body mass index, systolic blood pressure, fasting plasma glucose level, lipid profile, the HbA1c level at baseline and 3-year change in body mass index.
A higher baseline HbA1c level was not an independent risk factor for incident hypertension, whereas the change in HbA1c was independently associated with a greater longitudinal increase in blood pressure and an increased risk of incident hypertension in non-diabetic individuals.
糖尿病会增加患高血压的风险。糖化血红蛋白A1c(HbA1c)水平与新发高血压之间的关系仍存在争议。本研究调查了非糖尿病个体的基线HbA1c水平及其3年内的变化与新发高血压之间的关联。
本社区队列研究纳入了2591名年龄在40 - 75岁之间、基线时无高血压或糖尿病的个体,他们参与了一项纵向(REACTION)研究项目。在访谈期间进行问卷调查,并在基线(2011年)和随访(2014 - 2015年)时进行人体测量和实验室检测。应用多变量逻辑回归模型来估计新发高血压的比值比(OR)和95%置信区间(CI)。
在中位随访期3.08年(四分位间距3.00,3.25)内,384名(14.82%)受试者患上了高血压。在完全调整的线性回归模型中,HbA1c的变化仍与收缩压和舒张压的变化显著相关[β系数(95%CI),4.421(2.811 - 6.032),1.681(0.695 - 2.667)]。逻辑回归分析显示,在未调整模型中,基线HbA1c水平与新发高血压呈正相关;然而,进一步调整后该关联不再显著。HbA1c的变化与高血压的发生呈正相关,无论是作为按三分位数分层的分类变量[最高三分位数的调整OR(95%CI)为1.690(1.240 - 2.303),与最低三分位数相比]还是作为连续变量[调整OR(95%CI),1.242(1.106 - 1.394)],且独立于年龄、性别、体重指数、收缩压空腹血糖水平、血脂谱、基线HbA1c水平以及体重指数的3年变化。
较高的基线HbA1c水平不是新发高血压的独立危险因素,而HbA1c的变化与非糖尿病个体血压的更大纵向升高以及新发高血压风险增加独立相关。